Sanofi SA (SNY)
46.68
-1.00
(-2.10%)
USD |
NASDAQ |
Apr 24, 16:00
46.68
0.00 (0.00%)
After-Hours: 17:19
Sanofi Total Return Level: 101.78 for April 23, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 23, 2024 | 101.78 |
April 22, 2024 | 100.65 |
April 19, 2024 | 98.83 |
April 18, 2024 | 96.89 |
April 17, 2024 | 98.43 |
April 16, 2024 | 97.77 |
April 15, 2024 | 98.71 |
April 12, 2024 | 98.04 |
April 11, 2024 | 99.48 |
April 10, 2024 | 100.61 |
April 09, 2024 | 101.46 |
April 08, 2024 | 100.65 |
April 05, 2024 | 100.86 |
April 04, 2024 | 102.04 |
April 03, 2024 | 102.38 |
April 02, 2024 | 101.82 |
April 01, 2024 | 103.08 |
March 28, 2024 | 103.74 |
March 27, 2024 | 105.75 |
March 26, 2024 | 106.20 |
March 25, 2024 | 105.54 |
March 22, 2024 | 102.61 |
March 21, 2024 | 101.89 |
March 20, 2024 | 102.95 |
March 19, 2024 | 101.35 |
Date | Value |
---|---|
March 18, 2024 | 102.10 |
March 15, 2024 | 103.08 |
March 14, 2024 | 102.66 |
March 13, 2024 | 102.98 |
March 12, 2024 | 103.45 |
March 11, 2024 | 103.21 |
March 08, 2024 | 103.00 |
March 07, 2024 | 102.59 |
March 06, 2024 | 101.78 |
March 05, 2024 | 101.40 |
March 04, 2024 | 100.65 |
March 01, 2024 | 100.95 |
February 29, 2024 | 102.14 |
February 28, 2024 | 102.46 |
February 27, 2024 | 102.91 |
February 26, 2024 | 102.89 |
February 23, 2024 | 104.11 |
February 22, 2024 | 102.04 |
February 21, 2024 | 102.29 |
February 20, 2024 | 100.01 |
February 16, 2024 | 98.58 |
February 15, 2024 | 99.03 |
February 14, 2024 | 97.77 |
February 13, 2024 | 97.66 |
February 12, 2024 | 98.92 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
70.00
Minimum
Mar 20 2020
117.83
Maximum
Sep 20 2023
96.95
Average
98.01
Median
Aug 13 2020
Total Return Level Benchmarks
AstraZeneca PLC | 202.84 |
GSK PLC | 270.39 |
Novo Nordisk A/S | 223.83 |
Regeneron Pharmaceuticals Inc | 906.91 |
Inhibrx Inc | 34.10 |